SlideShare a Scribd company logo
1 of 79
Download to read offline
Pregnancy and Surgery- DoPregnancy and Surgery- Do
they mix?they mix?
Michael Rieker, DNP, CRNA, FAAN
Director, Nurse Anesthesia Program
Wake Forest Baptist Health
Surgery During Pregnancy:Surgery During Pregnancy:
How Frequent?How Frequent?
Swedish health-care registries: 0.75% or
5,405 out of 720,000 pregnancies
◦ Mazze. Am J Obstet Gynecol 1989;161:1178-85
US range is 1-2%
In US involves over 80,000 anesthetics each
year
Kuczkowski, K. (2006) The safety of anaesthetics in
pregnant women. Expert Opinion on Drug Safety. 5(2):251-
264.
Most Common Surgeries in PregnantMost Common Surgeries in Pregnant
PatientsPatients
Appendectomy
Cholecystectomy
Adnexal disease
Breast biopsy
Cervical cerclage
Ovarian cystectomy
Trauma
Intrauterine fetal surgery or exchange transfusion
Neurosurgery
◦ Nossek E. Ekstein M. Rimon E. Kupferminc MJ. Ram Z. Acta
Neurochirurgica. 2011;153(9):1727-35.
Important physiologic changesImportant physiologic changes
Airway
Mild hypervent/alkalosis
Prone to aspiration
Sensitive to drugs
Anemia, increased CO
Benign leukocytosis
Hypercoagulable
Rates of complicationsRates of complications
Maternal death rate: .006%
Miscarriage rate: 5.8%
Premature labor: 3.5%
Major birth defects with 1st
trim.
Surgery: 3.9%
 Cohen-Kerem R. Railton C. Oren D. Lishner M. Koren G. Pregnancy outcome
following non-obstetric surgical intervention. American Journal of Surgery.
190(3):467-73, 2005 Sep.
UI: 16105538
FETAL HAZARDSFETAL HAZARDS
• Exposure to teratogenic
drugs
• Risk of intraoperative
hypoxemia secondary to
reduced UBF
• Risk of preterm delivery
Principles of TeratologyPrinciples of Teratology
 The susceptibility of an embryo depends upon the
developmental stage at which the agent is applied
 Each teratogenic agent acts in a specific way on a particular
aspect of cellular metabolism
 The genotype influences to a greater or lesser degree an
animal’s reaction to a teratogenic agent
 An agent capable of causing malformation may also cause
an increase in embryonic mortality
 A teratogenic agent may not be deleterious to the
maternal organism (but may be)
Teratology- Timing is everythingTeratology- Timing is everything
Fetal Development: Period of HighFetal Development: Period of High
SusceptibilitySusceptibility
Period of greatest concern
begins at 15-18 days when
organogenesis begins
Reaches a peak at 30 days
postconception
Susceptibility decreases
until days 55-60 and
becomes minimal through
day 90
Anesthesia During Pregnancy
Implications for anesthetizing women of
child-bearing age…
General approachGeneral approach
Virtually all drugs cross to some degree
We really don’t know much about what a
given drug can or cannot do
Use any drug only when necessary, when
risk/benefit indicates, and then only in
minimal effective dose
Maternal/Fetal TransferMaternal/Fetal Transfer
Maternal/Fetal blood flow
Placental binding
Maternal, Placental,& Fetal metabolism
Diffusion capacity
Maternal & Fetal protein binding
Maternal Dose/Drug Uptake
Placental drug transferPlacental drug transfer
Depends upon:
◦ Physical and chemical properties of drug
◦ Characteristics of maternal, fetal, and placental
circulations
◦ Anatomy and physiology of the placenta
PLACENTAL TRANSPORTPLACENTAL TRANSPORT
Molecular weight
Lipid solubility
Ionization
Concentration gradient
Protein binding
Changes in maternal physiology
Route of delivery
Documented TeratogensDocumented Teratogens
ACE Inhibitors Mercury
Alcohol Phenytoin
Androgens PPIs (some evidence)
Antithyroid drugs Radiation (>5 rad)
Carbamazepine Streptomycin/kanamycin
Chemotherapy agents Isotretinoin (Accutane)
Cocaine Tetracycline
Coumadin Thalidomide
Diethylstibestrol Trimethadione
Lead Valproic acid
Lithium Vit A derivatives (Retinoic acid)
United States FDA Category Ratings ofUnited States FDA Category Ratings of
Drugs During PregnancyDrugs During Pregnancy
Category A: Controlled studies
demonstrate no risk.
Category B: No evidence of risks in
humans.
Category C: Risk cannot be ruled out.
Category D: Potential evidence of risk.
Category X: Contraindicated in
pregnancy.
United States FDA Category Ratings ofUnited States FDA Category Ratings of
Specific Anesthetic AgentsSpecific Anesthetic Agents
Anesthetic Agent
Induction Agents
Etomidate
Ketamine
Methohexital
Propofol
Thiopental
Inhaled Agents
Desflurane
Halothane
Isoflurane
Sevoflurane
Classification
C
B
B
B
C
B
C
C
B
United States FDA Category Ratings ofUnited States FDA Category Ratings of
Specific Anesthetic AgentsSpecific Anesthetic Agents (cont.)(cont.)
Anesthetic Agent
Local Anesthetics
2-Chloroprocaine
Bupivacaine
Lidocaine
Ropivacaine
Tetracaine
Opioids
Alfentanil
Fentanyl
Sufentanil
Meperidine
Morphine
Classification
C
C
B
B
B
C
C
C
C
C
United States FDA Category Ratings ofUnited States FDA Category Ratings of
Specific Anesthetic AgentsSpecific Anesthetic Agents (cont.)(cont.)
Anesthetic Agent
NMBD
Atracurium
Cisatracurium
Curare
Mivacurium
Pancuronium
Rocuronium
Succinylcholine
Vecuronium
Benzodiazepines
Diazepam
Midazolam
Classification
C
B
C
C
C
C
C
C
D
D
Teratogenic Effects of AnestheticsTeratogenic Effects of Anesthetics
Probably minimal to nonexistent and have never
been conclusively demonstrated
Drugs most common are N2O and
benzodiazepines
N2O probably teratogenic in animals because of
reduced UBF; this can be prevented by addition of
a halogenated agent
Inhalational agents, narcotics, intravenous agents,
local anesthetics have a long history of safety
when used during pregnancy
TeratogenicityTeratogenicity
NO anesthetic agent (except cocaine) in
normal clinical doses has been PROVEN to
be teratogenic in humans.
No anesthetic agent has been PROVEN to
induce preterm labor and/or delivery
Inhalation agentsInhalation agents
Lipid solubility promotes transfer
Duration of exposure relates to APGAR
Iso, nitrous: F/M 0.7 even with short
exposure
Oxygen
Do volatiles harm the baby in utero?Do volatiles harm the baby in utero?
50 women- GA with ½ MAC Des/Sevo
compared with epidural
No difference in APGAR or
neurobehavioral scores
 The Maternal and Neonatal Effects of the Volatile Anaesthetic Agents
Desflurane and Sevoflurane in Caesarean Section: a Prospective, Randomized
Clinical Study Karaman, S.; Akercan, F.; Aldemir, O.; Terek, M.C.; Yalaz,
M.; Firat, V. The Journal of International Medical Research, 34 (2) 2006, pp.
183-192
Nitrous oxide concernsNitrous oxide concerns
Oxidizes cobalt atom on
Vit B12
Inhibits methionine
synthetase and
tetrahydrofolate
Concern for DNA
production
Demyelination with long-
term exposure
IV inductionsIV inductions
Thiopental, methohexital, ketamine achieve F/M
around 1.0
Propofol and etomidate: lower F/M then
pentothal (0.6)
One study = lower APGARs with prop.
Good for hypotension, better at preventing
awareness
Package Insert-BenzodiazepinesPackage Insert-Benzodiazepines
“An increased risk of congenital
malformations associated with the use of
benzodiazepine drugs (diazepam and
chlordiazepoxide) has been suggested in
several studies. If this drug is used during
pregnancy, the patient should be appraised
of potential risk to fetus.”
OpioidsOpioids
Morphine, demerol, sufenta, stadol, nubain
cross readily and achieve > 50% fetal
concentration
Protein-binding limits transfer- fent and
alfenta stay < 0.5
Remi crosses to high conc, but little
evidence of neonatal effects
Spinal/epidural route does not preclude fetal
transfer
Local AnestheticsLocal Anesthetics
Readily cross placenta.
Controversy regarding fetal/neonatal effects
Most conclusive: cause “transient, minor
neurobehavioral effects”
Muscle relaxantsMuscle relaxants
Ionized drugs- little transfer
Sux shows up in UV only after large doses
NDMRs have F/M < 0.15
Anticholinergics/Anticholinergics/
AnticholinesterasesAnticholinesterasesAtropine
Scopolamine
Glycopyrrolate
Neostigmine
What would standard neostig/robinul
reversal do?
AntihypertensivesAntihypertensives
β-blockers- No
Clonidine/methyldopa: OK
Hydralazine: choice drug
SNP: lipid soluble- rapidly crosses
ACE inhibitors- No
VasopressorsVasopressors
Concern for uterine vasoconstriction
Ephedrine mainstay
Phenylephrine gaining acceptance for safety
in moderate doses, and without unwanted
tachycardia
Antiasthmatic drugsAntiasthmatic drugs
Theophylline: safe (class C)
Terbutaline
Isoproterenol, metaproterenol: insignificant
systemic absorption when inhaled. IV use
may dec UBF
Cromolyn: OK
Steroids
AnticoagulantsAnticoagulants
Warfarin- causes fetal loss or
chondrodysplasia
Avoided in 1st
trim, but most switch to
heparin throughout pregnancy
AntiepilepticsAntiepileptics
Magnesium Sulfate
Phenytoin (Dilantin)
Phenobarbital
Carbamazepine (Tegretol)
AntiemeticsAntiemetics
Ondansetron
Significant findings re: cleftSignificant findings re: cleft
palatepalate
Conflicting dataConflicting data
 Danish registry covering from1997-2010 (897,018
pregnant women). In contrast to earlier studies from same
registry, found a 2-fold increased risk of cardiac
malformations with ondansetron (odds ratio 2.0; 95%
confidence interval 1.3–3.1), leading to an overall 30%
increased risk of major congenital malformations. To rule
out confounding by indication, also examined
metoclopramide taken for morning sickness, detecting no
increase in teratogenic risk.
 Andersen, J.T., Jimmenez-Solem, E., and Andersen, N.L. Ondansetron use in
early pregnancy and the risk of congenital malformations. Int Soc
Pharmacoepidemiol. 2013;
Anesthesia During Pregnancy
Anesthesia During Pregnancy
AntibioticsAntibiotics
Penicillins, cephalosporins, EES: OK
Sulfonamides: compete with bili for albumin
binding
Tetracycline: OK, except for teeth
Aminoglycosides
AnalgesicsAnalgesics
Aspirin
Acetaminophen
Propoxyphene
Codeine
Teratogenicity of Anesthetic AgentsTeratogenicity of Anesthetic Agents
Maternal hemodynamic changes more
critical than specific agents in most cases
Avoid at all costs maternal HYPOXIA,
HYPOTENSION, HYPERCARBIA,
HYPERTHERMIA
"All things are poison and
nothing is without poison,
only the dose permits
something not to be
poisonous."
~Paracelcus
“Because it is clear that virtually every drug
and every inhalation anesthetic are
teratogenic to some species under certain
conditions, there is no “best” anesthetic
agent.”
Kuczkowski, K. “Nonobstetric surgery in the parturient:
anesthetic considerations”. Journal of Clinical Anesthesia
(2006) 28, 5-7
RECOMMENDATIONSRECOMMENDATIONS
Use drugs with a long history of safe clinical
use
Document apgar scores
FETAL HAZARDSFETAL HAZARDS
• Exposure to teratogenic drugs
• Risk of intraoperative
hypoxemia secondary to
reduced UBF
• Risk of preterm delivery
UTERINE BLOOD FLOWUTERINE BLOOD FLOW
uterine arterial pressure – uterine venous pressure
uterine vascular resistance
Systemic hypotension
Supine hypotension
Vasopressors
Sick placentas
Uterine tone
HypotensionHypotension
Hypovolemia, anesthetics, aortocaval
compression
IV bolus, but careful of pulm edema
LaparoscopyLaparoscopy
Left uterine displacement
maintaining ETCO2 32-34 mmHg
 maternal BP within 20% of baseline
Limit insufflation pressure to 12-15 mmHg
 O'Rourke N. Kodali BS. Laparoscopic surgery during pregnancy. Current
Opinion in Anaesthesiology. 19(3):254-9, 2006 Jun.
What about EFM?What about EFM?
Can obtain FHR after about 18 wks
Variability begins ~25 weeks
Should use after 22-24 wks
“What are you going to do differently?”
Management of Anesthesia for theManagement of Anesthesia for the
Pregnant Surgical PatientPregnant Surgical Patient
Severe Fetal Bradycardia in a Pregnant Surgical PatientSevere Fetal Bradycardia in a Pregnant Surgical Patient
Despite Normal Oxygenation and Blood PressureDespite Normal Oxygenation and Blood Pressure
Some obstetricians believe fetus would not
be compromised as long as maternal
oxygenation, circulation normal
27 yo, 34 week gestation; FHR < 70 bpm
with normal maternal hemodynamics
Emergency section; Apgar 1, 5, 7
Ong BY et al: Can J Anesth 50(922):2003
Arguments Against RoutineArguments Against Routine
EFMEFM
Anesthesia has been associated with predictable
changes in FHR that does not result in fetal mortality
Continuous EFM could lead to the false impressions
of fetal distress with maternal-fetal harm
Continuous EFM has not been clearly shown to
prevent poor fetal outcomes
EFM is impractical for many urgent/emergent
procedures
Interpretation of continuous EFM requires
experience not common to OR personnel
Anesthesia During Pregnancy
Management of FHR Abnormalities:Management of FHR Abnormalities:
Optimize maternal oxygenation, ventilation,
acid-base status
Expand maternal blood volume
Increased maternal perfusion pressure
Increased maternal oxygen-carrying
capacity
LUD, repositioning surgical retractors
Perioperative ManagementPerioperative Management
Preoperative Assessment
◦ Should include pregnancy testing if diagnosis in doubt;
mandatory testing is controversial
◦ Date of LMP should be documented on anesthetic
record in any female between age 12-50
◦ Offer testing if more than 3 weeks from LMP or if
patient requests
If Pregnant
◦ Premedicate to reduce anxiety, catechols, impact UBF
◦ Consider aspiration prophylaxis
◦ Discuss perioperative tocolysis with obstetrician
Principles for Anesthetic Management ofPrinciples for Anesthetic Management of
the Parturient <24 Weeks Gestationthe Parturient <24 Weeks Gestation
 Postpone surgery until second trimester, if possible
 Request preoperative assessment by an obstetrician
 Counsel the patient preoperatively
 Use a nonparticulate antacid as aspiration prophylaxis
 Monitor and maintain oxygenation, normocarbia,
normotension, normothermia, and euglycemia
 Use regional anesthesia when appropriate
 Avoid N2O in high concentrations during general anesthesia?
 Document fetal heart tones before and after the procedure
Principles for Anesthetic Management ofPrinciples for Anesthetic Management of
the Parturient >24 Weeks Gestationthe Parturient >24 Weeks Gestation
 Counsel the patient preoperatively
 Discuss use of prophylactic tocolytic agents with the
obstetrician
 aspiration prophylaxis
 Maintain left uterine displacement pre-, intra-, and
postoperatively
 Monitor and maintain oxygenation, normocarbia,
normotension, normothermia, and euglycemia
 Use fetal monitoring intraoperatively when possible to
optimize the intrauterine environment; monitor for
uterine contractions postoperatively
Practical PointsPractical Points
Never sacrifice maternal safety
If feasible, regional anesthesia preferable
No evidence of any anesthetic technique better
than another as long as maternal oxygenation,
perfusion maintained
Uterine displacement essential beyond 20 weeks
Use pharmacologic aspiration prophylaxis, RSI,
cricoid pressure
Secure airway quickly as oxygen levels fall quickly
Maintain maternal glucose above 70 mg/dL
Practical PointsPractical Points
Avoid BNZ
Keep inhalation agents below 1 MAC to prevent
decreased maternal CO
Be aware of reduced drug requirements for
regional or general anesthesia
Minimize stimulation of uterine contractions by
appropriate anesthetic techniques, optimal surgical
conditions, cautious reversal, tocolytics if indicated
FETAL HAZARDSFETAL HAZARDS
• Exposure to teratogenic drugs
• Risk of intraoperative
hypoxemia secondary to
reduced UBF
• Risk of preterm delivery
FETAL HAZARDSFETAL HAZARDS
• Exposure to teratogenic drugs
• Risk of intraoperative
hypoxemia secondary to
reduced UBF
• Risk of preterm delivery
Does exposure toDoes exposure to
anesthetics increase theanesthetics increase the
risk of spontaneousrisk of spontaneous
abortion?abortion?
Allaert SE. et. Al. Acta Anaesthesiologica Belgica.
2007;58(2):119-23.
Mazze RI, Kallen B. Reproductive outcome after
anaesthesia and operation during pregnancy: a
registry study of 5405 cases. Am J Obstet Gynecol
1989;161:1178-85
Do we cause it?Do we cause it?
Hong. Adnexal mass surgery and anesthesia
during pregnancy: a 10-year retrospective
review.
Int J Obstet Anesth. 2006 Jul;15(3):212-6.
Preterm laborPreterm labor
We don’t specifically treat preventatively
Maintain homeostasis
Postoperative ManagementPostoperative Management
Monitor FHR, uterine activity
Maintain maternal monitoring
Left uterine displacement
Manage preterm labor aggressively
◦ Indomethacin
◦ Magnesium sulfate
◦ Terbutaline
Postoperative ManagementPostoperative Management
Chance of spont Ab only in first week.
After that risk is no higher than normal
Toco useful, as analgesics may mask
awareness of contractions
Pain may encourage premature labor
Hypercoagulable
Drugs used during lactationDrugs used during lactation
Drugs used during lactationDrugs used during lactation
Passage goes back to Fick’s principle
Amount in breast milk is a fraction of blood
level and usually has no or negligible effects
on neonate
Some drugs are concentrated in milk
Anesthetic drug transfer into breastAnesthetic drug transfer into breast
milkmilk
0.005% (range, 0.002%-0.013%) of the maternal
midazolam dose
0.027% (0.004%-0.082%) of the propofol dose
0.033% (0.006%-0.073%) of the fentanyl dose
represent averages of 0.009%, 0.025%, and 0.039%
of the respective elimination clearances.
 Nitsun M. Szokol JW. Saleh HJ. Murphy GS. Vender JS. Luong L. Raikoff K. Avram MJ.
Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human
breast milk. Clinical Pharmacology & Therapeutics. 79(6):549-57, 2006 Jun.
CautionsCautions
Toxic drugs are never acceptable
Neonatal allergies
Like most things, inadequate controlled
studies of outcomes
Reduced maternal or infant ability to
metabolize drug may concentrate it
General principlesGeneral principles
Post-partum, colostrum mostly. Little drug
excreted
Time administration to follow feeding
Avoid long-acting drugs
American Academy of PediatricsAmerican Academy of Pediatrics
Drugs whose effects are unknown, but may be a
concern:
 Psychotropics
 Metronidazole
Drugs that are contraindicated:
 Marijuana
 Phencyclidine
 Nicotine
 Cocaine
 Heroin
 Amphetamines
Drugs usually compatible withDrugs usually compatible with
breast feedingbreast feeding
Opioids, sedatives, anticonvulsants
No obvious adverse effects
Breast milk has only 1-2% of maternal conc
Lipid sol like valium or barbs may cross to a
greater extent, and elimination is slow
American Academy ofAmerican Academy of
PediatricsPediatrics
◦ Drugs and lactation database (LactMed)
http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
Drugs and Breast feedingDrugs and Breast feeding
Decide if drug therapy is really necessary
Use the safest drug
Consider monitoring drug concentrations
Minimize exposure: feed before dosing
What 8 things can I do today?What 8 things can I do today?
Review changes of pregnancy
Postpone case; at least until after 1st
trimester
Avoid supine position after 24 weeks
Carefully approach airway- RSI after 1st
trim.
Select drugs with good safety record; use regional
when possible
Assess FHR a & p if > 24 weeks.
Modest doses of almost any typical drugs will be
OK
Avoid hypotension, keep slightly hypocarbic

More Related Content

What's hot

Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesWahid altaf Sheeba hakak
 
Controlled hypotension in anesthesia
Controlled hypotension in anesthesiaControlled hypotension in anesthesia
Controlled hypotension in anesthesiaTenzin yoezer
 
ANAESTHESIA FOR FETAL SURGERY
ANAESTHESIA FOR FETAL SURGERYANAESTHESIA FOR FETAL SURGERY
ANAESTHESIA FOR FETAL SURGERYDr Krunal Bhatt
 
anaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyanaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyabhijit wagh
 
Anaesthesia for non obstetric surgery in pregnancy
Anaesthesia for non obstetric surgery in pregnancyAnaesthesia for non obstetric surgery in pregnancy
Anaesthesia for non obstetric surgery in pregnancyDr Nandini Deshpande
 
Obs anaesthesia
Obs anaesthesiaObs anaesthesia
Obs anaesthesiaManu Gupta
 
Anaesthesia outside operating room
Anaesthesia outside operating roomAnaesthesia outside operating room
Anaesthesia outside operating roomnarasimha reddy
 
DIFFERENT PATIENT POSITIONING IN ANAESTHESIA
DIFFERENT PATIENT POSITIONING IN ANAESTHESIADIFFERENT PATIENT POSITIONING IN ANAESTHESIA
DIFFERENT PATIENT POSITIONING IN ANAESTHESIAAryaDasmahapatra
 
Anatomy of epidural space
Anatomy of epidural spaceAnatomy of epidural space
Anatomy of epidural spaceKarthavya S L
 
Minimum alveolar concentration (mac)
Minimum alveolar concentration (mac)Minimum alveolar concentration (mac)
Minimum alveolar concentration (mac)Torrentz Tiku
 
Anesthesia ForPregnancy induced hypertension
Anesthesia ForPregnancy induced hypertension Anesthesia ForPregnancy induced hypertension
Anesthesia ForPregnancy induced hypertension krishna dhakal
 
Physiological Changes in Pregnancy and Its Anaesthetic Implications.
Physiological Changes in Pregnancy and Its Anaesthetic Implications.Physiological Changes in Pregnancy and Its Anaesthetic Implications.
Physiological Changes in Pregnancy and Its Anaesthetic Implications.Mohtasib Madaoo
 
Anesthesia for non Obstetric Surgery in Pregnancy
Anesthesia for non Obstetric Surgery in PregnancyAnesthesia for non Obstetric Surgery in Pregnancy
Anesthesia for non Obstetric Surgery in Pregnancyisakakinada
 
Interscalene & supraclavicular nerve blocks
Interscalene  & supraclavicular nerve blocksInterscalene  & supraclavicular nerve blocks
Interscalene & supraclavicular nerve blocksDavis Kurian
 
Difficult airway
Difficult airwayDifficult airway
Difficult airwayimran80
 

What's hot (20)

Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergencies
 
Controlled hypotension in anesthesia
Controlled hypotension in anesthesiaControlled hypotension in anesthesia
Controlled hypotension in anesthesia
 
Pre-oxygenation
Pre-oxygenationPre-oxygenation
Pre-oxygenation
 
ANAESTHESIA FOR FETAL SURGERY
ANAESTHESIA FOR FETAL SURGERYANAESTHESIA FOR FETAL SURGERY
ANAESTHESIA FOR FETAL SURGERY
 
anaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyanaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomy
 
Anaesthesia for non obstetric surgery in pregnancy
Anaesthesia for non obstetric surgery in pregnancyAnaesthesia for non obstetric surgery in pregnancy
Anaesthesia for non obstetric surgery in pregnancy
 
Obs anaesthesia
Obs anaesthesiaObs anaesthesia
Obs anaesthesia
 
Anaesthesia outside operating room
Anaesthesia outside operating roomAnaesthesia outside operating room
Anaesthesia outside operating room
 
DIFFERENT PATIENT POSITIONING IN ANAESTHESIA
DIFFERENT PATIENT POSITIONING IN ANAESTHESIADIFFERENT PATIENT POSITIONING IN ANAESTHESIA
DIFFERENT PATIENT POSITIONING IN ANAESTHESIA
 
Anatomy of epidural space
Anatomy of epidural spaceAnatomy of epidural space
Anatomy of epidural space
 
Minimum alveolar concentration (mac)
Minimum alveolar concentration (mac)Minimum alveolar concentration (mac)
Minimum alveolar concentration (mac)
 
Anesthesia ForPregnancy induced hypertension
Anesthesia ForPregnancy induced hypertension Anesthesia ForPregnancy induced hypertension
Anesthesia ForPregnancy induced hypertension
 
Labor analgesia
Labor analgesiaLabor analgesia
Labor analgesia
 
ASRA Guidelines
ASRA GuidelinesASRA Guidelines
ASRA Guidelines
 
Intravenous induction agents
Intravenous induction agentsIntravenous induction agents
Intravenous induction agents
 
Physiological Changes in Pregnancy and Its Anaesthetic Implications.
Physiological Changes in Pregnancy and Its Anaesthetic Implications.Physiological Changes in Pregnancy and Its Anaesthetic Implications.
Physiological Changes in Pregnancy and Its Anaesthetic Implications.
 
Anesthesia for non Obstetric Surgery in Pregnancy
Anesthesia for non Obstetric Surgery in PregnancyAnesthesia for non Obstetric Surgery in Pregnancy
Anesthesia for non Obstetric Surgery in Pregnancy
 
Interscalene & supraclavicular nerve blocks
Interscalene  & supraclavicular nerve blocksInterscalene  & supraclavicular nerve blocks
Interscalene & supraclavicular nerve blocks
 
Difficult airway
Difficult airwayDifficult airway
Difficult airway
 
Awake intubation
Awake intubationAwake intubation
Awake intubation
 

Viewers also liked

Non Obstet Surgery
Non Obstet SurgeryNon Obstet Surgery
Non Obstet SurgeryPritesh Vyas
 
Sudip presentation
Sudip presentationSudip presentation
Sudip presentationSudip Saha
 
Management of pregnant patients in oral surgery
Management of pregnant patients in oral surgeryManagement of pregnant patients in oral surgery
Management of pregnant patients in oral surgeryManjari Reshikesh
 
Anesthetic complications in pregnancy
Anesthetic complications in pregnancyAnesthetic complications in pregnancy
Anesthetic complications in pregnancyRodolfo Granados
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageSasidhar Puvvula
 
Obstetrical Anesthesia
Obstetrical AnesthesiaObstetrical Anesthesia
Obstetrical AnesthesiaBitew Mekonnen
 
Manag of pregnant woman in dental clinic
Manag of pregnant woman in dental clinicManag of pregnant woman in dental clinic
Manag of pregnant woman in dental clinicimelhakim
 
Local anesthetics agents
Local anesthetics agentsLocal anesthetics agents
Local anesthetics agentsIyad Abou Rabii
 
기형학의 원칙
기형학의 원칙기형학의 원칙
기형학의 원칙mothersafe
 
PV bleeding and pain in early pregnancy
PV bleeding and pain in early pregnancyPV bleeding and pain in early pregnancy
PV bleeding and pain in early pregnancySCGH ED CME
 
obstetric emergencies
 obstetric emergencies obstetric emergencies
obstetric emergenciesisakakinada
 
Anesthesia Management in COPD Patients
Anesthesia Management in COPD PatientsAnesthesia Management in COPD Patients
Anesthesia Management in COPD PatientsReza Aminnejad
 
Evaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary riskEvaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary riskNahid Sherbini
 
Anesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addictsAnesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addictsAftab Hussain
 

Viewers also liked (20)

Non Obstet Surgery
Non Obstet SurgeryNon Obstet Surgery
Non Obstet Surgery
 
Sudip presentation
Sudip presentationSudip presentation
Sudip presentation
 
Management of pregnant patients in oral surgery
Management of pregnant patients in oral surgeryManagement of pregnant patients in oral surgery
Management of pregnant patients in oral surgery
 
Anesthetic complications in pregnancy
Anesthetic complications in pregnancyAnesthetic complications in pregnancy
Anesthetic complications in pregnancy
 
Social Media Lecture
Social Media LectureSocial Media Lecture
Social Media Lecture
 
Political Primer 2015
Political Primer 2015Political Primer 2015
Political Primer 2015
 
Exploration of Postoperative Nausea and Vomiting
Exploration of Postoperative Nausea and VomitingExploration of Postoperative Nausea and Vomiting
Exploration of Postoperative Nausea and Vomiting
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhage
 
Obstetrical Anesthesia
Obstetrical AnesthesiaObstetrical Anesthesia
Obstetrical Anesthesia
 
Manag of pregnant woman in dental clinic
Manag of pregnant woman in dental clinicManag of pregnant woman in dental clinic
Manag of pregnant woman in dental clinic
 
Local anesthetics agents
Local anesthetics agentsLocal anesthetics agents
Local anesthetics agents
 
Uncommon obstetrical procedures
Uncommon obstetrical proceduresUncommon obstetrical procedures
Uncommon obstetrical procedures
 
기형학의 원칙
기형학의 원칙기형학의 원칙
기형학의 원칙
 
PV bleeding and pain in early pregnancy
PV bleeding and pain in early pregnancyPV bleeding and pain in early pregnancy
PV bleeding and pain in early pregnancy
 
Anesthesia and Asthma
Anesthesia and AsthmaAnesthesia and Asthma
Anesthesia and Asthma
 
Anesthesiology Information
Anesthesiology InformationAnesthesiology Information
Anesthesiology Information
 
obstetric emergencies
 obstetric emergencies obstetric emergencies
obstetric emergencies
 
Anesthesia Management in COPD Patients
Anesthesia Management in COPD PatientsAnesthesia Management in COPD Patients
Anesthesia Management in COPD Patients
 
Evaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary riskEvaluation of preoperative pulmonary risk
Evaluation of preoperative pulmonary risk
 
Anesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addictsAnesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addicts
 

Similar to Anesthesia During Pregnancy

Update in anesthesia for non obstetric surgery in pregnency
Update in anesthesia for non obstetric surgery in pregnencyUpdate in anesthesia for non obstetric surgery in pregnency
Update in anesthesia for non obstetric surgery in pregnencymamunur1
 
Drugs in pregnancy&lactation
Drugs in pregnancy&lactationDrugs in pregnancy&lactation
Drugs in pregnancy&lactationWALID SARHAN
 
incidental surgery during pregnancy.pptx
incidental surgery during pregnancy.pptxincidental surgery during pregnancy.pptx
incidental surgery during pregnancy.pptxMisganawMengie
 
Repro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfRepro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfSanjayaManiDixit
 
Intra-uterine fetal death and Post-term pregnancy
Intra-uterine fetal death and Post-term pregnancyIntra-uterine fetal death and Post-term pregnancy
Intra-uterine fetal death and Post-term pregnancyLipi Mondal
 
Dental Procedure (Tooth extraction) During Pregnancy.pptx
Dental Procedure (Tooth extraction) During Pregnancy.pptxDental Procedure (Tooth extraction) During Pregnancy.pptx
Dental Procedure (Tooth extraction) During Pregnancy.pptxssuserd85ab4
 
Efectos fetales de la anestesia espinal materna
Efectos fetales de la anestesia espinal maternaEfectos fetales de la anestesia espinal materna
Efectos fetales de la anestesia espinal maternaAnestesia Dolor
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyabhishekbharti51
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptxBAPIRAJU4
 
ESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancyESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancyAinshamsCardio
 
Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancyVerdah Sabih
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)drmcbansal
 
Epilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptxEpilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptxYasser Alzainy
 
Epilepsy in women
Epilepsy in womenEpilepsy in women
Epilepsy in womenPS Deb
 
HOW TO OPTIMIZE ART OUTCOME
HOW TO OPTIMIZE ART OUTCOMEHOW TO OPTIMIZE ART OUTCOME
HOW TO OPTIMIZE ART OUTCOMEDrRokeyaBegum
 
Critical Care in Pregnancy
Critical Care in PregnancyCritical Care in Pregnancy
Critical Care in PregnancyOmar Khaled
 

Similar to Anesthesia During Pregnancy (20)

Update in anesthesia for non obstetric surgery in pregnency
Update in anesthesia for non obstetric surgery in pregnencyUpdate in anesthesia for non obstetric surgery in pregnency
Update in anesthesia for non obstetric surgery in pregnency
 
Drugs in pregnancy&lactation
Drugs in pregnancy&lactationDrugs in pregnancy&lactation
Drugs in pregnancy&lactation
 
Threatened abortion
Threatened abortion Threatened abortion
Threatened abortion
 
incidental surgery during pregnancy.pptx
incidental surgery during pregnancy.pptxincidental surgery during pregnancy.pptx
incidental surgery during pregnancy.pptx
 
Repro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfRepro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdf
 
Intra-uterine fetal death and Post-term pregnancy
Intra-uterine fetal death and Post-term pregnancyIntra-uterine fetal death and Post-term pregnancy
Intra-uterine fetal death and Post-term pregnancy
 
4493677.ppt
4493677.ppt4493677.ppt
4493677.ppt
 
Dental Procedure (Tooth extraction) During Pregnancy.pptx
Dental Procedure (Tooth extraction) During Pregnancy.pptxDental Procedure (Tooth extraction) During Pregnancy.pptx
Dental Procedure (Tooth extraction) During Pregnancy.pptx
 
Pharmacology of obstetrics . satya pptx
Pharmacology of  obstetrics . satya  pptxPharmacology of  obstetrics . satya  pptx
Pharmacology of obstetrics . satya pptx
 
Anaesthesia for LSCS
Anaesthesia for LSCSAnaesthesia for LSCS
Anaesthesia for LSCS
 
Efectos fetales de la anestesia espinal materna
Efectos fetales de la anestesia espinal maternaEfectos fetales de la anestesia espinal materna
Efectos fetales de la anestesia espinal materna
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancy
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
ESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancyESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancy
 
Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancy
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)
 
Epilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptxEpilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptx
 
Epilepsy in women
Epilepsy in womenEpilepsy in women
Epilepsy in women
 
HOW TO OPTIMIZE ART OUTCOME
HOW TO OPTIMIZE ART OUTCOMEHOW TO OPTIMIZE ART OUTCOME
HOW TO OPTIMIZE ART OUTCOME
 
Critical Care in Pregnancy
Critical Care in PregnancyCritical Care in Pregnancy
Critical Care in Pregnancy
 

More from NC Association of Nurse Anesthetists

Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris Saraceno
Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris SaracenoUsing Arterial Pressure Based Cardiac Output to Guide Therapy - Chris Saraceno
Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris SaracenoNC Association of Nurse Anesthetists
 
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the Future
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the FutureGoal Directed Fluid Therapy: Fact, Fiction, Findings and the Future
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the FutureNC Association of Nurse Anesthetists
 
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia Techniques
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia TechniquesFundamentals of Ultrasound Guided Peripheral Regional Anesthesia Techniques
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia TechniquesNC Association of Nurse Anesthetists
 
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, AlternativesAnesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, AlternativesNC Association of Nurse Anesthetists
 

More from NC Association of Nurse Anesthetists (20)

Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris Saraceno
Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris SaracenoUsing Arterial Pressure Based Cardiac Output to Guide Therapy - Chris Saraceno
Using Arterial Pressure Based Cardiac Output to Guide Therapy - Chris Saraceno
 
What's New in Cardiac
What's New in CardiacWhat's New in Cardiac
What's New in Cardiac
 
All Sugars Are Not Created Equal - Kimberli Zecchin
All Sugars Are Not Created Equal - Kimberli ZecchinAll Sugars Are Not Created Equal - Kimberli Zecchin
All Sugars Are Not Created Equal - Kimberli Zecchin
 
Postoperative Vision Loss - Kathy Alwon
Postoperative Vision Loss - Kathy AlwonPostoperative Vision Loss - Kathy Alwon
Postoperative Vision Loss - Kathy Alwon
 
CPC Program Requirements
CPC Program RequirementsCPC Program Requirements
CPC Program Requirements
 
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the Future
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the FutureGoal Directed Fluid Therapy: Fact, Fiction, Findings and the Future
Goal Directed Fluid Therapy: Fact, Fiction, Findings and the Future
 
How to Prepare for the Next Big Epidemiological Event
How to Prepare for the Next Big Epidemiological EventHow to Prepare for the Next Big Epidemiological Event
How to Prepare for the Next Big Epidemiological Event
 
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia Techniques
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia TechniquesFundamentals of Ultrasound Guided Peripheral Regional Anesthesia Techniques
Fundamentals of Ultrasound Guided Peripheral Regional Anesthesia Techniques
 
Fast Tracking Ambulatory Surgery Patients
Fast Tracking Ambulatory Surgery PatientsFast Tracking Ambulatory Surgery Patients
Fast Tracking Ambulatory Surgery Patients
 
Pain Management: Updating the Outdated
Pain Management: Updating the OutdatedPain Management: Updating the Outdated
Pain Management: Updating the Outdated
 
Anesthesia on Safari
Anesthesia on SafariAnesthesia on Safari
Anesthesia on Safari
 
Anesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine SurgeryAnesthetic Aspects of Endocrine Surgery
Anesthetic Aspects of Endocrine Surgery
 
Excuse Me, Is this Allergen Free
Excuse Me, Is this Allergen FreeExcuse Me, Is this Allergen Free
Excuse Me, Is this Allergen Free
 
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, AlternativesAnesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
 
TEE Workshop
TEE WorkshopTEE Workshop
TEE Workshop
 
Uncommon obstetrical procedures
Uncommon obstetrical proceduresUncommon obstetrical procedures
Uncommon obstetrical procedures
 
Joseph McVicker NCANA
Joseph McVicker NCANAJoseph McVicker NCANA
Joseph McVicker NCANA
 
NCANA PTSD EMERGENCE DELIRIUM
NCANA PTSD EMERGENCE DELIRIUM NCANA PTSD EMERGENCE DELIRIUM
NCANA PTSD EMERGENCE DELIRIUM
 
Awake intubation distribution
Awake intubation distributionAwake intubation distribution
Awake intubation distribution
 
Propofol ketamine technique for rapid turnover
Propofol ketamine technique for rapid turnoverPropofol ketamine technique for rapid turnover
Propofol ketamine technique for rapid turnover
 

Recently uploaded

Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxSaurabhParmar42
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 

Recently uploaded (20)

Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptx
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 

Anesthesia During Pregnancy

  • 1. Pregnancy and Surgery- DoPregnancy and Surgery- Do they mix?they mix? Michael Rieker, DNP, CRNA, FAAN Director, Nurse Anesthesia Program Wake Forest Baptist Health
  • 2. Surgery During Pregnancy:Surgery During Pregnancy: How Frequent?How Frequent? Swedish health-care registries: 0.75% or 5,405 out of 720,000 pregnancies ◦ Mazze. Am J Obstet Gynecol 1989;161:1178-85 US range is 1-2% In US involves over 80,000 anesthetics each year Kuczkowski, K. (2006) The safety of anaesthetics in pregnant women. Expert Opinion on Drug Safety. 5(2):251- 264.
  • 3. Most Common Surgeries in PregnantMost Common Surgeries in Pregnant PatientsPatients Appendectomy Cholecystectomy Adnexal disease Breast biopsy Cervical cerclage Ovarian cystectomy Trauma Intrauterine fetal surgery or exchange transfusion Neurosurgery ◦ Nossek E. Ekstein M. Rimon E. Kupferminc MJ. Ram Z. Acta Neurochirurgica. 2011;153(9):1727-35.
  • 4. Important physiologic changesImportant physiologic changes Airway Mild hypervent/alkalosis Prone to aspiration Sensitive to drugs Anemia, increased CO Benign leukocytosis Hypercoagulable
  • 5. Rates of complicationsRates of complications Maternal death rate: .006% Miscarriage rate: 5.8% Premature labor: 3.5% Major birth defects with 1st trim. Surgery: 3.9%  Cohen-Kerem R. Railton C. Oren D. Lishner M. Koren G. Pregnancy outcome following non-obstetric surgical intervention. American Journal of Surgery. 190(3):467-73, 2005 Sep. UI: 16105538
  • 6. FETAL HAZARDSFETAL HAZARDS • Exposure to teratogenic drugs • Risk of intraoperative hypoxemia secondary to reduced UBF • Risk of preterm delivery
  • 7. Principles of TeratologyPrinciples of Teratology  The susceptibility of an embryo depends upon the developmental stage at which the agent is applied  Each teratogenic agent acts in a specific way on a particular aspect of cellular metabolism  The genotype influences to a greater or lesser degree an animal’s reaction to a teratogenic agent  An agent capable of causing malformation may also cause an increase in embryonic mortality  A teratogenic agent may not be deleterious to the maternal organism (but may be)
  • 8. Teratology- Timing is everythingTeratology- Timing is everything
  • 9. Fetal Development: Period of HighFetal Development: Period of High SusceptibilitySusceptibility Period of greatest concern begins at 15-18 days when organogenesis begins Reaches a peak at 30 days postconception Susceptibility decreases until days 55-60 and becomes minimal through day 90
  • 11. Implications for anesthetizing women of child-bearing age…
  • 12. General approachGeneral approach Virtually all drugs cross to some degree We really don’t know much about what a given drug can or cannot do Use any drug only when necessary, when risk/benefit indicates, and then only in minimal effective dose
  • 13. Maternal/Fetal TransferMaternal/Fetal Transfer Maternal/Fetal blood flow Placental binding Maternal, Placental,& Fetal metabolism Diffusion capacity Maternal & Fetal protein binding Maternal Dose/Drug Uptake
  • 14. Placental drug transferPlacental drug transfer Depends upon: ◦ Physical and chemical properties of drug ◦ Characteristics of maternal, fetal, and placental circulations ◦ Anatomy and physiology of the placenta
  • 15. PLACENTAL TRANSPORTPLACENTAL TRANSPORT Molecular weight Lipid solubility Ionization Concentration gradient Protein binding Changes in maternal physiology Route of delivery
  • 16. Documented TeratogensDocumented Teratogens ACE Inhibitors Mercury Alcohol Phenytoin Androgens PPIs (some evidence) Antithyroid drugs Radiation (>5 rad) Carbamazepine Streptomycin/kanamycin Chemotherapy agents Isotretinoin (Accutane) Cocaine Tetracycline Coumadin Thalidomide Diethylstibestrol Trimethadione Lead Valproic acid Lithium Vit A derivatives (Retinoic acid)
  • 17. United States FDA Category Ratings ofUnited States FDA Category Ratings of Drugs During PregnancyDrugs During Pregnancy Category A: Controlled studies demonstrate no risk. Category B: No evidence of risks in humans. Category C: Risk cannot be ruled out. Category D: Potential evidence of risk. Category X: Contraindicated in pregnancy.
  • 18. United States FDA Category Ratings ofUnited States FDA Category Ratings of Specific Anesthetic AgentsSpecific Anesthetic Agents Anesthetic Agent Induction Agents Etomidate Ketamine Methohexital Propofol Thiopental Inhaled Agents Desflurane Halothane Isoflurane Sevoflurane Classification C B B B C B C C B
  • 19. United States FDA Category Ratings ofUnited States FDA Category Ratings of Specific Anesthetic AgentsSpecific Anesthetic Agents (cont.)(cont.) Anesthetic Agent Local Anesthetics 2-Chloroprocaine Bupivacaine Lidocaine Ropivacaine Tetracaine Opioids Alfentanil Fentanyl Sufentanil Meperidine Morphine Classification C C B B B C C C C C
  • 20. United States FDA Category Ratings ofUnited States FDA Category Ratings of Specific Anesthetic AgentsSpecific Anesthetic Agents (cont.)(cont.) Anesthetic Agent NMBD Atracurium Cisatracurium Curare Mivacurium Pancuronium Rocuronium Succinylcholine Vecuronium Benzodiazepines Diazepam Midazolam Classification C B C C C C C C D D
  • 21. Teratogenic Effects of AnestheticsTeratogenic Effects of Anesthetics Probably minimal to nonexistent and have never been conclusively demonstrated Drugs most common are N2O and benzodiazepines N2O probably teratogenic in animals because of reduced UBF; this can be prevented by addition of a halogenated agent Inhalational agents, narcotics, intravenous agents, local anesthetics have a long history of safety when used during pregnancy
  • 22. TeratogenicityTeratogenicity NO anesthetic agent (except cocaine) in normal clinical doses has been PROVEN to be teratogenic in humans. No anesthetic agent has been PROVEN to induce preterm labor and/or delivery
  • 23. Inhalation agentsInhalation agents Lipid solubility promotes transfer Duration of exposure relates to APGAR Iso, nitrous: F/M 0.7 even with short exposure Oxygen
  • 24. Do volatiles harm the baby in utero?Do volatiles harm the baby in utero? 50 women- GA with ½ MAC Des/Sevo compared with epidural No difference in APGAR or neurobehavioral scores  The Maternal and Neonatal Effects of the Volatile Anaesthetic Agents Desflurane and Sevoflurane in Caesarean Section: a Prospective, Randomized Clinical Study Karaman, S.; Akercan, F.; Aldemir, O.; Terek, M.C.; Yalaz, M.; Firat, V. The Journal of International Medical Research, 34 (2) 2006, pp. 183-192
  • 25. Nitrous oxide concernsNitrous oxide concerns Oxidizes cobalt atom on Vit B12 Inhibits methionine synthetase and tetrahydrofolate Concern for DNA production Demyelination with long- term exposure
  • 26. IV inductionsIV inductions Thiopental, methohexital, ketamine achieve F/M around 1.0 Propofol and etomidate: lower F/M then pentothal (0.6) One study = lower APGARs with prop. Good for hypotension, better at preventing awareness
  • 27. Package Insert-BenzodiazepinesPackage Insert-Benzodiazepines “An increased risk of congenital malformations associated with the use of benzodiazepine drugs (diazepam and chlordiazepoxide) has been suggested in several studies. If this drug is used during pregnancy, the patient should be appraised of potential risk to fetus.”
  • 28. OpioidsOpioids Morphine, demerol, sufenta, stadol, nubain cross readily and achieve > 50% fetal concentration Protein-binding limits transfer- fent and alfenta stay < 0.5 Remi crosses to high conc, but little evidence of neonatal effects Spinal/epidural route does not preclude fetal transfer
  • 29. Local AnestheticsLocal Anesthetics Readily cross placenta. Controversy regarding fetal/neonatal effects Most conclusive: cause “transient, minor neurobehavioral effects”
  • 30. Muscle relaxantsMuscle relaxants Ionized drugs- little transfer Sux shows up in UV only after large doses NDMRs have F/M < 0.15
  • 32. AntihypertensivesAntihypertensives β-blockers- No Clonidine/methyldopa: OK Hydralazine: choice drug SNP: lipid soluble- rapidly crosses ACE inhibitors- No
  • 33. VasopressorsVasopressors Concern for uterine vasoconstriction Ephedrine mainstay Phenylephrine gaining acceptance for safety in moderate doses, and without unwanted tachycardia
  • 34. Antiasthmatic drugsAntiasthmatic drugs Theophylline: safe (class C) Terbutaline Isoproterenol, metaproterenol: insignificant systemic absorption when inhaled. IV use may dec UBF Cromolyn: OK Steroids
  • 35. AnticoagulantsAnticoagulants Warfarin- causes fetal loss or chondrodysplasia Avoided in 1st trim, but most switch to heparin throughout pregnancy
  • 38. Significant findings re: cleftSignificant findings re: cleft palatepalate
  • 39. Conflicting dataConflicting data  Danish registry covering from1997-2010 (897,018 pregnant women). In contrast to earlier studies from same registry, found a 2-fold increased risk of cardiac malformations with ondansetron (odds ratio 2.0; 95% confidence interval 1.3–3.1), leading to an overall 30% increased risk of major congenital malformations. To rule out confounding by indication, also examined metoclopramide taken for morning sickness, detecting no increase in teratogenic risk.  Andersen, J.T., Jimmenez-Solem, E., and Andersen, N.L. Ondansetron use in early pregnancy and the risk of congenital malformations. Int Soc Pharmacoepidemiol. 2013;
  • 42. AntibioticsAntibiotics Penicillins, cephalosporins, EES: OK Sulfonamides: compete with bili for albumin binding Tetracycline: OK, except for teeth Aminoglycosides
  • 44. Teratogenicity of Anesthetic AgentsTeratogenicity of Anesthetic Agents Maternal hemodynamic changes more critical than specific agents in most cases Avoid at all costs maternal HYPOXIA, HYPOTENSION, HYPERCARBIA, HYPERTHERMIA
  • 45. "All things are poison and nothing is without poison, only the dose permits something not to be poisonous." ~Paracelcus
  • 46. “Because it is clear that virtually every drug and every inhalation anesthetic are teratogenic to some species under certain conditions, there is no “best” anesthetic agent.” Kuczkowski, K. “Nonobstetric surgery in the parturient: anesthetic considerations”. Journal of Clinical Anesthesia (2006) 28, 5-7
  • 47. RECOMMENDATIONSRECOMMENDATIONS Use drugs with a long history of safe clinical use Document apgar scores
  • 48. FETAL HAZARDSFETAL HAZARDS • Exposure to teratogenic drugs • Risk of intraoperative hypoxemia secondary to reduced UBF • Risk of preterm delivery
  • 49. UTERINE BLOOD FLOWUTERINE BLOOD FLOW uterine arterial pressure – uterine venous pressure uterine vascular resistance Systemic hypotension Supine hypotension Vasopressors Sick placentas Uterine tone
  • 51. LaparoscopyLaparoscopy Left uterine displacement maintaining ETCO2 32-34 mmHg  maternal BP within 20% of baseline Limit insufflation pressure to 12-15 mmHg  O'Rourke N. Kodali BS. Laparoscopic surgery during pregnancy. Current Opinion in Anaesthesiology. 19(3):254-9, 2006 Jun.
  • 52. What about EFM?What about EFM? Can obtain FHR after about 18 wks Variability begins ~25 weeks Should use after 22-24 wks “What are you going to do differently?”
  • 53. Management of Anesthesia for theManagement of Anesthesia for the Pregnant Surgical PatientPregnant Surgical Patient
  • 54. Severe Fetal Bradycardia in a Pregnant Surgical PatientSevere Fetal Bradycardia in a Pregnant Surgical Patient Despite Normal Oxygenation and Blood PressureDespite Normal Oxygenation and Blood Pressure Some obstetricians believe fetus would not be compromised as long as maternal oxygenation, circulation normal 27 yo, 34 week gestation; FHR < 70 bpm with normal maternal hemodynamics Emergency section; Apgar 1, 5, 7 Ong BY et al: Can J Anesth 50(922):2003
  • 55. Arguments Against RoutineArguments Against Routine EFMEFM Anesthesia has been associated with predictable changes in FHR that does not result in fetal mortality Continuous EFM could lead to the false impressions of fetal distress with maternal-fetal harm Continuous EFM has not been clearly shown to prevent poor fetal outcomes EFM is impractical for many urgent/emergent procedures Interpretation of continuous EFM requires experience not common to OR personnel
  • 57. Management of FHR Abnormalities:Management of FHR Abnormalities: Optimize maternal oxygenation, ventilation, acid-base status Expand maternal blood volume Increased maternal perfusion pressure Increased maternal oxygen-carrying capacity LUD, repositioning surgical retractors
  • 58. Perioperative ManagementPerioperative Management Preoperative Assessment ◦ Should include pregnancy testing if diagnosis in doubt; mandatory testing is controversial ◦ Date of LMP should be documented on anesthetic record in any female between age 12-50 ◦ Offer testing if more than 3 weeks from LMP or if patient requests If Pregnant ◦ Premedicate to reduce anxiety, catechols, impact UBF ◦ Consider aspiration prophylaxis ◦ Discuss perioperative tocolysis with obstetrician
  • 59. Principles for Anesthetic Management ofPrinciples for Anesthetic Management of the Parturient <24 Weeks Gestationthe Parturient <24 Weeks Gestation  Postpone surgery until second trimester, if possible  Request preoperative assessment by an obstetrician  Counsel the patient preoperatively  Use a nonparticulate antacid as aspiration prophylaxis  Monitor and maintain oxygenation, normocarbia, normotension, normothermia, and euglycemia  Use regional anesthesia when appropriate  Avoid N2O in high concentrations during general anesthesia?  Document fetal heart tones before and after the procedure
  • 60. Principles for Anesthetic Management ofPrinciples for Anesthetic Management of the Parturient >24 Weeks Gestationthe Parturient >24 Weeks Gestation  Counsel the patient preoperatively  Discuss use of prophylactic tocolytic agents with the obstetrician  aspiration prophylaxis  Maintain left uterine displacement pre-, intra-, and postoperatively  Monitor and maintain oxygenation, normocarbia, normotension, normothermia, and euglycemia  Use fetal monitoring intraoperatively when possible to optimize the intrauterine environment; monitor for uterine contractions postoperatively
  • 61. Practical PointsPractical Points Never sacrifice maternal safety If feasible, regional anesthesia preferable No evidence of any anesthetic technique better than another as long as maternal oxygenation, perfusion maintained Uterine displacement essential beyond 20 weeks Use pharmacologic aspiration prophylaxis, RSI, cricoid pressure Secure airway quickly as oxygen levels fall quickly Maintain maternal glucose above 70 mg/dL
  • 62. Practical PointsPractical Points Avoid BNZ Keep inhalation agents below 1 MAC to prevent decreased maternal CO Be aware of reduced drug requirements for regional or general anesthesia Minimize stimulation of uterine contractions by appropriate anesthetic techniques, optimal surgical conditions, cautious reversal, tocolytics if indicated
  • 63. FETAL HAZARDSFETAL HAZARDS • Exposure to teratogenic drugs • Risk of intraoperative hypoxemia secondary to reduced UBF • Risk of preterm delivery
  • 64. FETAL HAZARDSFETAL HAZARDS • Exposure to teratogenic drugs • Risk of intraoperative hypoxemia secondary to reduced UBF • Risk of preterm delivery
  • 65. Does exposure toDoes exposure to anesthetics increase theanesthetics increase the risk of spontaneousrisk of spontaneous abortion?abortion? Allaert SE. et. Al. Acta Anaesthesiologica Belgica. 2007;58(2):119-23. Mazze RI, Kallen B. Reproductive outcome after anaesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989;161:1178-85
  • 66. Do we cause it?Do we cause it? Hong. Adnexal mass surgery and anesthesia during pregnancy: a 10-year retrospective review. Int J Obstet Anesth. 2006 Jul;15(3):212-6.
  • 67. Preterm laborPreterm labor We don’t specifically treat preventatively Maintain homeostasis
  • 68. Postoperative ManagementPostoperative Management Monitor FHR, uterine activity Maintain maternal monitoring Left uterine displacement Manage preterm labor aggressively ◦ Indomethacin ◦ Magnesium sulfate ◦ Terbutaline
  • 69. Postoperative ManagementPostoperative Management Chance of spont Ab only in first week. After that risk is no higher than normal Toco useful, as analgesics may mask awareness of contractions Pain may encourage premature labor Hypercoagulable
  • 70. Drugs used during lactationDrugs used during lactation
  • 71. Drugs used during lactationDrugs used during lactation Passage goes back to Fick’s principle Amount in breast milk is a fraction of blood level and usually has no or negligible effects on neonate Some drugs are concentrated in milk
  • 72. Anesthetic drug transfer into breastAnesthetic drug transfer into breast milkmilk 0.005% (range, 0.002%-0.013%) of the maternal midazolam dose 0.027% (0.004%-0.082%) of the propofol dose 0.033% (0.006%-0.073%) of the fentanyl dose represent averages of 0.009%, 0.025%, and 0.039% of the respective elimination clearances.  Nitsun M. Szokol JW. Saleh HJ. Murphy GS. Vender JS. Luong L. Raikoff K. Avram MJ. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clinical Pharmacology & Therapeutics. 79(6):549-57, 2006 Jun.
  • 73. CautionsCautions Toxic drugs are never acceptable Neonatal allergies Like most things, inadequate controlled studies of outcomes Reduced maternal or infant ability to metabolize drug may concentrate it
  • 74. General principlesGeneral principles Post-partum, colostrum mostly. Little drug excreted Time administration to follow feeding Avoid long-acting drugs
  • 75. American Academy of PediatricsAmerican Academy of Pediatrics Drugs whose effects are unknown, but may be a concern:  Psychotropics  Metronidazole Drugs that are contraindicated:  Marijuana  Phencyclidine  Nicotine  Cocaine  Heroin  Amphetamines
  • 76. Drugs usually compatible withDrugs usually compatible with breast feedingbreast feeding Opioids, sedatives, anticonvulsants No obvious adverse effects Breast milk has only 1-2% of maternal conc Lipid sol like valium or barbs may cross to a greater extent, and elimination is slow
  • 77. American Academy ofAmerican Academy of PediatricsPediatrics ◦ Drugs and lactation database (LactMed) http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  • 78. Drugs and Breast feedingDrugs and Breast feeding Decide if drug therapy is really necessary Use the safest drug Consider monitoring drug concentrations Minimize exposure: feed before dosing
  • 79. What 8 things can I do today?What 8 things can I do today? Review changes of pregnancy Postpone case; at least until after 1st trimester Avoid supine position after 24 weeks Carefully approach airway- RSI after 1st trim. Select drugs with good safety record; use regional when possible Assess FHR a & p if > 24 weeks. Modest doses of almost any typical drugs will be OK Avoid hypotension, keep slightly hypocarbic